ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 060,84
0,80%
Dow Jones
38 957,69
0,27%
DAX
18 399,58
1,25%
Brent Oil
82,655
-0,98%
Bitcoin
63 781,59
0,97%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ProKidney Corporation (PROK)

  7. ProKidney Corporation (PROK) Actualités

PROK ProKidney Corporation

2,255
0,015 (0,67%)
Dernière mise à jour : 16:38:19
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ProKidney Corporation PROK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,015 0,67% 2,255 16:38:19
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,24 2,1903 2,265 2,24
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/3/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 8-K - Current report
06/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202422:19EDGAR2Form 8-K - Current report
19/1/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/202322:06EDGAR2Form 8-K/A - Current report: [Amend]
05/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
30/11/202312:58EDGAR2Form 8-K - Current report
22/11/202315:22EDGAR2Form S-3 - Registration statement under Securities Act of..
20/11/202312:11EDGAR2Form 8-K - Current report
14/11/202312:09EDGAR2Form 8-K - Current report
13/11/202323:28EDGAR2Form 8-K - Current report
30/10/202321:12GLOBEProKidney Announces Four Abstracts Selected for Presentation..
11/9/202314:01EDGAR2Form 8-K - Current report
05/9/202312:05GLOBEProKidney to Participate in Fireside Chat at the Morgan..
30/8/202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202322:07EDGAR2Form POS AM - Post-Effective amendments for registration..
11/8/202315:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/8/202322:33EDGAR2Form 8-K - Current report
10/8/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:10GLOBEProKidney Reports Second Quarter Financial Results and..
03/8/202314:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/7/202322:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/7/202314:01EDGAR2Form 8-K - Current report
18/7/202312:05GLOBEProKidney Announces Closing of Purchase of Manufacturing..
17/7/202312:05GLOBEProKidney Appoints Bruce Culleton, MD, as Executive Vice..
06/7/202322:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/7/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202322:06EDGAR2Form 8-K - Current report
13/6/202318:05GLOBEProKidney Announces Purchase of Manufacturing Facility in..
01/6/202322:05GLOBEProKidney to Participate in Fireside Chat at the Jefferies..
11/5/202322:01GLOBEProKidney Reports First Quarter Financial Results and Recent..

Dernières Valeurs Consultées

NASDAQ
PROK
ProKidney
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés